St. Louis, MO, 25 April, 2025 – Leinco Technologies, a leading innovator in life science research and diagnostic solutions, is proud to announce the launch of its ADAPT-3D Tissue Clearing Kit. This new offering is designed to significantly enhance 3D fluorescence imaging, providing researchers with an advanced, versatile tool to visualize biological tissues at unprecedented depths and clarity.

ADAPT-3D (Accelerated Deep Adaptable Processing of Tissue for 3-Dimensional Fluorescence Tissue Imaging) represents a breakthrough in tissue processing protocols. Leveraging cutting-edge technology, this product allows for rapid refractive index matching (RIM) and efficient antibody staining, while preserving tissue morphology and fluorescence intensity. Unlike traditional methods that can take several days to complete, ADAPT-3D achieves uniform RIM in just hours, making it ideal for applications across a wide range of tissue types and models.

Key Features and Benefits of ADAPT-3D include:

  • Rapid Processing: Achieves refractive index matching in minutes to hours, drastically reducing preparation time compared to conventional methods.
  • Broad Compatibility: Suitable for various tissue types, including brain, liver, and intestinal tissues, ensuring versatility in research and clinical settings.
  • Preservation of Morphology and Fluorescence: Minimizes distortion and maintains high-quality fluorescence for deep tissue imaging.
  • Non-Toxic: ADAPT-3D eliminates the need for harmful chemicals, providing a safer alternative for laboratory environments.

“We are excited to introduce ADAPT-3D as a game-changer for the life sciences community,” said Wm. Pat Leinert, President and CEO of Leinco Technologies. “This product not only improves the speed and efficiency of tissue imaging but also enhances the quality of results, enabling researchers to gain deeper insights into complex biological systems. ADAPT-3D is an important addition to our portfolio of solutions that are driving the future of biomedical research.”

ADAPT-3D has already shown significant promise in preclinical testing, demonstrating its ability to clear thick tissue samples with unmatched transparency and precision. Early applications include 3D imaging of brain and gut tissue, providing unprecedented visualization of cellular and structural details. With its user-friendly protocol and rapid processing capabilities, ADAPT-3D is poised to become an indispensable tool in laboratories worldwide.
For more information about ADAPT-3D and to request a demonstration, please visit www.leinco.com.

About Leinco Technologies Inc.

Leinco Technologies is a leader in the development and production of high-quality antibodies, proteins, and diagnostic tools for scientific research, diagnostics, and therapeutics. With a strong focus on innovation and scientific excellence, Leinco Technologies supports advancements in areas such as cancer research, immunology, and tissue imaging, providing cutting-edge solutions for global health challenges.